The once-daily semaglutide tablet may be prescribed alongside diet and physical activity for adults with obesity or overweight plus a weight-related condition
Semaglutide is a GLP-1 receptor agonist primarily used as a treatment for diabetes (Ozempic, Novo Nordisk) and more recently greenlit as a breakthrough treatment for obesity (Wegovy, Novo Nordisk)
These interesting findings may be also attributed to the weight reduction properties
How GLP-1 Medications Affect Muscle Mass GLP-1 agonists like Ozempic, Wegovy, and Mounjaro can be powerful tools for body weight management because they reduce hunger and help you sustain a calorie deficit
These are major developments for the worlds food and drink producers, and farmers, whether they realise it or not
Weight loss of around 1015% leads to remission of T2DM in patients with early T2DM [32, 33]